Clinical Trials Directory

Trials / Completed

CompletedNCT05090631

The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh Population

Preventive and Personalized Medicine (2021-2023)

Status
Completed
Phase
Study type
Observational
Enrollment
600 (actual)
Sponsor
Asfendiyarov Kazakh National Medical University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This is a GWAS study that aims to identify possible candidate genes associate to atopic dermatitisby exploring single nucleotide polymorphism (SNP) in a group of atopic dermatitis, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with atopic dermatitis

Detailed description

A genome-wide association study (GWAS) is an approach used in genetics research to associate specific genetic variations with particular diseases. The method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease. Once such genetic markers are identified, they can be used to understand how genes contribute to the disease and develop better prevention and treatment strategies.

Conditions

Interventions

TypeNameDescription
GENETICDNA analysisGWAS

Timeline

Start date
2021-10-23
Primary completion
2023-01-20
Completion
2023-01-20
First posted
2021-10-25
Last updated
2023-03-14

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT05090631. Inclusion in this directory is not an endorsement.